weeks; patients received flexible dosing of oral aripiprazole 10–30 mg/day and were seen biweekly for assessments); and an open- label AOM 400 maintenance phase (phase 3, 52 weeks; patients were seen weekly for the first 4 weeks, biweekly for weeks 6–12, and every 4 weeks through ...